Inpatient Hospice Transitions Checklist for Dementia

(I-HTC Trial)

KP
Overseen ByKomal P Murali, PhD, RN, ACNP-BC
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: New York University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new tool, the Inpatient Hospice Transitions Checklist (I-HTC), to assist doctors and caregivers in discussing hospice care for hospitalized dementia patients. The goal is to improve decision-making for patients who cannot make decisions themselves. This study targets hospitalized individuals with dementia whose doctors have indicated they might be nearing the end of life. As an unphased trial, it offers a unique opportunity to contribute to research that could enhance decision-making processes for end-of-life care.

What prior data suggests that the Inpatient Hospice Transitions Checklist is safe for use with hospitalized persons living with dementia?

Research has shown that the Inpatient Hospice Transitions Checklist (I-HTC) improves communication between healthcare providers and caregivers of people with dementia. Although the checklist itself poses no specific safety concerns, it is part of hospice care, which has been studied for safety in various settings.

Hospice care aims to support and comfort patients with serious illnesses, such as dementia. Studies have demonstrated that hospice care quality, including emotional support, scores well, with ratings ranging from 69.0 to 90.9 out of 100. This suggests that patients and families often have positive experiences. Furthermore, effective communication in hospice care correlates with better outcomes, such as fewer in-hospital deaths for dementia patients.

In summary, while direct safety data for the checklist is lacking, related hospice care practices are considered supportive and generally well-received by patients and their families.12345

Why are researchers excited about this trial?

The Inpatient Hospice Transitions Checklist (I-HTC) is unique because it offers a structured approach to easing the transition from hospital to hospice care for patients with dementia. Unlike current standard care, which often varies widely and may lack consistency, I-HTC provides a specific checklist that helps healthcare providers communicate more effectively with the families and caregivers of dementia patients. Researchers are excited about this trial because they hope it will lead to more seamless transitions, reduce stress for both caregivers and patients, and ultimately improve the quality of end-of-life care for individuals with dementia.

What evidence suggests that the Inpatient Hospice Transitions Checklist is effective for dementia?

Research has shown that improving the transition of dementia patients from hospital to home can lead to better outcomes. One study found that the health and well-being of caregivers significantly influence how well adults with dementia fare after hospital discharge. Another review highlights that personalized care can help avoid unnecessary hospital visits for patients nearing the end of life. Understanding the shift to hospice care is also crucial for managing healthcare use among people with dementia. This trial will evaluate the effectiveness of the Inpatient Hospice Transitions Checklist (I-HTC) in enhancing communication and decision-making. These findings suggest that tools like the I-HTC could improve care for those with dementia.36789

Are You a Good Fit for This Trial?

This trial is for people with dementia who are hospitalized and may be nearing the end of life. The study focuses on patients whose care teams are considering hospice as an option.

Inclusion Criteria

I am an adult surrogate involved in care discussions and can communicate in English.
Clinicians must be physicians, nurse practitioners, physician assistants, nurses, or social workers practicing in acute care; participate in goals-of-care, advance care planning (ACP), hospice, or care transition discussions for hospitalized adults with dementia; complete study activities in English; and use the electronic health record (EPIC) for clinical documentation and patient care
I am 60 or older, in the hospital, have dementia, and can't make my own medical decisions.

Exclusion Criteria

I am not the main decision-maker and can't reach the legal representative for consent.
Clinicians who do not routinely participate in ACP, hospice, or care transition communication; decline or do not complete required training; or share responsibility for a patient encounter with an enrolled senior clinician

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention Development and Adaptation

Development and adaptation of the Inpatient Hospice Transitions Checklist (I-HTC) through surveys and training with clinicians

4-6 weeks

Feasibility Pilot

Single-arm feasibility pilot involving clinicians and patient-surrogate dyads to test the I-HTC intervention

1 month

Follow-up

Participants are monitored for feasibility, usability, and communication quality after intervention

1 month

What Are the Treatments Tested in This Trial?

Interventions

  • Inpatient Hospice Transitions Checklist (I-HTC)

Trial Overview

The study is testing a new checklist tool (I-HTC) built into hospital records to help doctors and families talk about hospice care options for patients with dementia. All participants receive this intervention; there is no comparison group.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Usual Care ArmExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

New York University

Lead Sponsor

Trials
249
Recruited
229,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

NYU Langone Health

Collaborator

Trials
1,431
Recruited
838,000+

Citations

1.

pubmed.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov/35081914/

Impact of home healthcare on end-of-life outcomes for ...

This review highlights the dearth of dementia-specific research regarding the impact of HHC on end-of-life outcomes. Effects of advance care ...

IMPROVING CARE TRANSITIONS FOR DEMENTIA ...

During care transitions from hospital to home, outcomes for adults with dementia depend, in part, on the caregiver's health and well-being ...

Understanding which people with dementia are at risk ...

Objective: to investigate determinants of end-of-life hospital transitions, and association with healthcare use, among people with dementia.

How Coastal Hospice Improved Clinical Outcomes with AI

The palliative data tool has also measured clinical capacity needs, as well as improvements in patient and family satisfaction, according to ...

(PDF) Hospice Care for Patients with Dementia

Decedent diagnoses were as follows: dementia, n=8,686 (11.3%); cancer, n=35,693 (46.3%); and other chronic diseases, n=32,744 (42.4%). Decedents ...

Hospice Experiences Vary by Care Setting for Patients ...

According to study results, “Mean quality measure scores ranged from 69.0 (Getting Hospice Care Training) to 90.9 (Getting Emotional Support).”.

Association Between Place of Death and Patient Safety Culture

Residents with dementia in NHs with higher PSC scores in communication openness had lower odds of in-hospital death. This effect was stronger in NHs located in ...

CARE TRANSITIONS NOTEBOOK

Care transitions: the 30 days … ▪ Denial ▪ Anger ▪ Removing yourself from friends/family and activities ▪ Anxiety/nervousness ▪ Depression ▪ Exhaustion

Advance Care Planning and Hospice Use Among People ...

Patients enrolled in HCW were proportionally less likely to be admitted to the ICU (12.5% vs. 17.8%) and were more likely to be “do not ...